Lipopolysaccharide-induced chorioamnionitis promotes il-1-dependent inflammatory FOXP3+ CD4+ t cells in the fetal rhesus macaque

Journal of Immunology

Volumn 196, Issue 9, 2016, Pages 3706-3715

  Rueda, Cesar M ^a,b   Presicce, Pietro ^c   Jackson, Courtney M ^a,b   Miller, Lisa A ^d,e   Kallapur, Suhas G ^c   Jobe, Alan H ^c   Chougnet, Claire A ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHORIOAMNIONITIS; CONTROLLED STUDY; FEMALE; FETUS; FOXP3+ CD4+ T LYMPHOCYTE; INFLAMMATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHESUS MONKEY; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE; TH17 CELL; THYMUS; ANIMAL; DISEASE MODEL; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TRENDS;

ANIMALS; CHORIOAMNIONITIS; DISEASE MODELS, ANIMAL; FEMALE; FETUS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; MACACA MULATTA; OBSTETRIC LABOR, PREMATURE; PREGNANCY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84974806035     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502613     Document Type: Article

References (83)

1. Gravett, M. G., C. E. Rubens, Global Alliance to Prevent Prematurity and Stillbirth Technical Team. 2012. A framework for strategic investments in research to reduce the global burden of preterm birth. Am. J. Obstet. Gynecol. 207: 368-373.
2. Erdemir, G., N. Kultursay, S. Calkavur, O. Zekioglu, O. A. Koroglu, B. Cakmak, M. Yalaz, M. Akisu, and S. Sagol. 2013. Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr. Neonatol. 54: 267-274.
3. Romero, R., J. C. Grivel, A. L. Tarca, P. Chaemsaithong, Z. Xu, W. Fitzgerald, S. S. Hassan, T. Chaiworapongsa, and L. Margolis. 2015. Evidence of perturbations of the cytokine network in preterm labor. Am. J. Obstet. Gynecol. 213: 836.e1-836.e18.
4. Goldenberg, R. L., J. C. Hauth, and W. W. Andrews. 2000. Intrauterine infection and preterm delivery. N. Engl. J. Med. 342: 1500-1507.
5. Gonçalves, L. F., T. Chaiworapongsa, and R. Romero. 2002. Intrauterine infection and prematurity. Ment. Retard. Dev. Disabil. Res. Rev. 8: 3-13.
6. Kallapur, S. G., P. Presicce, P. Senthamaraikannan, M. Alvarez, A. F. Tarantal, L. M. Miller, A. H. Jobe, and C. A. Chougnet. 2013. Intra-amniotic IL-1b induces fetal inflammation in rhesus monkeys and alters the regulatory T cell/IL-17 balance. J. Immunol. 191: 1102-1109.
7. Kallapur, S. G., P. Presicce, C. M. Rueda, A. H. Jobe, and C. A. Chougnet. 2014. Fetal immune response to chorioamnionitis. Semin. Reprod. Med. 32: 56-67.
8. Strunk, T., D. Doherty, A. Jacques, K. Simmer, P. Richmond, R. Kohan, A. Charles, and D. Burgner. 2012. Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics 129: e134-e141.
9. Romero, R., F. Gotsch, B. Pineles, and J. P. Kusanovic. 2007. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr. Rev. 65: S194-S202.
10. De Felice, C., G. Latini, A. Del Vecchio, P. Toti, F. Bagnoli, and F. Petraglia. 2002. Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. Pediatrics 110: 386-388.
11. De Felice, C., P. Toti, R. Santopietro, M. Stumpo, L. Pecciarini, and F. Bagnoli. 1999. Small thymus in very low birth weight infants born to mothers with subclinical chorioamnionitis. J. Pediatr. 135: 384-386.
12. Toti, P., C. De Felice, M. Stumpo, K. Schurfeld, L. Di Leo, R. Vatti, G. Bianciardi, G. Buonocore, T. A. Seemayer, and P. Luzi. 2000. Acute thymic involution in fetuses and neonates with chorioamnionitis. Hum. Pathol. 31: 1121-1128.
13. Di Naro, E., A. Cromi, F. Ghezzi, L. Raio, S. Uccella, V. D'Addario, and G. Loverro. 2006. Fetal thymic involution: a sonographic marker of the fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 194: 153-159.
14. El-Haieg, D. O., A. A. Zidan, and M. M. El-Nemr. 2008. The relationship between sonographic fetal thymus size and the components of the systemic fetal inflammatory response syndrome in women with preterm prelabour rupture of membranes. BJOG 115: 836-841.
15. Yinon, Y., Y. Zalel, B. Weisz, S. Mazaki-Tovi, E. Sivan, E. Schiff, and R. Achiron. 2007. Fetal thymus size as a predictor of chorioamnionitis in women with preterm premature rupture of membranes. Ultrasound Obstet. Gynecol. 29: 639-643.
16. Jeppesen, D. L. 2003. The size of the thymus: an important immunological diagnostic tool? Acta Paediatr. 92: 994-996.
17. Gravett, M. G., G. J. Haluska, M. J. Cook, and M. J. Novy. 1996. Fetal and maternal endocrine responses to experimental intrauterine infection in rhesus monkeys. Am. J. Obstet. Gynecol. 174: 1725-1731, discussion 1731-1733.
18. Sadowsky, D. W., K. M. Adams, M. G. Gravett, S. S. Witkin, and M. J. Novy. 2006. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 195: 1578-1589.
19. Presicce, P., P. Senthamaraikannan, M. Alvarez, C. M. Rueda, M. Cappelletti, L. A. Miller, A. H. Jobe, C. A. Chougnet, and S. G. Kallapur. 2015. Neutrophil recruitment and activation in decidua with intra-amniotic IL-1beta in the preterm rhesus macaque. Biol. Reprod. 92: 56
20. Rendon, J. L., and M. A. Choudhry. 2012. Th17 cells: critical mediators of host responses to burn injury and sepsis. J. Leukoc. Biol. 92: 529-538.
21. Rubino, S. J., K. Geddes, and S. E. Girardin. 2012. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol. 33: 112-118.
22. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-βeta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397.
23. Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11: 7-13.
24. + T cells in vivo. J. Immunol. 186: 6329-6337.
25. +CD25-naive T cells to CD4 +CD25+ regulatory T cells by TGF-βeta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
26. Hori, S. 2014. Lineage stability and phenotypic plasticity of Foxp3? regulatory T cells. Immunol. Rev. 259: 159-172.
27. +Treg in the presence of lineage-specific polarizing factors. Proc. Natl. Acad. Sci. USA 107: 19402-19407.
28. Mercer, F., A. Khaitan, L. Kozhaya, J. A. Aberg, and D. Unutmaz. 2014. Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors. J. Immunol. 193: 1047-1054.
29. + regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 106: 4793-4798.
30. + T cells capable of producing proinflammatory cytokines. Blood 121: 2647-2658.
31. Keelan, J. A., P. M. Wong, P. S. Bird, and M. D. Mitchell. 2010. Innate inflammatory responses of human decidual cells to periodontopathic bacteria. Am. J. Obstet. Gynecol. 202: 471.e1-471.e11.
32. Spits, H. 2002. Development of alphabeta T cells in the human thymus. Nat. Rev. Immunol. 2: 760-772.
33. Plum, J., M. De Smedt, G. Leclercq, T. Taghon, T. Kerre, and B. Vandekerckhove. 2008. Human intrathymic development: a selective approach. Semin. Immunopathol. 30: 411-423.
34. Vanhecke, D., B. Verhasselt, M. De Smedt, G. Leclercq, J. Plum, and B. Vandekerckhove. 1997. Human thymocytes become lineage committed at an early postselection CD69+ stage, before the onset of functional maturation. J. Immunol. 159: 5973-5983.
35. Vanhecke, D., B. Verhasselt, M. De Smedt, B. De Paepe, G. Leclercq, J. Plum, and B. Vandekerckhove. 1997. MHC class II molecules are required for initiation of positive selection but not during terminal differentiation of human CD4 single positive thymocytes. J. Immunol. 158: 3730-3737.
36. Romero, R., and B. Tartakovsky. 1992. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am. J. Obstet. Gynecol. 167: 1041-1045.
37. Kallapur, S. G., I. Nitsos, T. J. Moss, G. R. Polglase, J. J. Pillow, F. C. Cheah, B. W. Kramer, J. P. Newnham, M. Ikegami, and A. H. Jobe. 2009. IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide. Am. J. Respir. Crit. Care Med. 179: 955-961.
38. Nadeau-Vallée, M., C. Quiniou, J. Palacios, X. Hou, A. Erfani, A. Madaan, M. Sanchez, K. Leimert, A. Boudreault, F. Duhamel, et al. 2015. Novel non-competitive IL-1 receptor-biased ligand prevents infection-and inflammationinduced preterm birth. J. Immunol. 195: 3402-3415.
39. Aksentijevich, I., S. L. Masters, P. J. Ferguson, P. Dancey, J. Frenkel, A. van Royen-Kerkhoff, R. Laxer, U. Tedgard, E. W. Cowen, T. H. Pham, et al. 2009. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 360: 2426-2437.
40. Goldbach-Mansky, R., N. J. Dailey, S. W. Canna, A. Gelabert, J. Jones, B. I. Rubin, H. J. Kim, C. Brewer, C. Zalewski, E. Wiggs, et al. 2006. Neonatalonset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med. 355: 581-592.
41. Fox, E., N. Jayaprakash, T. H. Pham, A. Rowley, C. L. McCully, F. Pucino, and R. Goldbach-Mansky. 2010. The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates. J. Neuroimmunol. 223: 138-140.
42. Baergen, R., K. Benirschke, and T. R. Ulich. 1994. Cytokine expression in the placenta. The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition. Arch. Pathol. Lab. Med. 118: 52-55.
43. Lahra, M. M., and H. E. Jeffery. 2004. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am. J. Obstet. Gynecol. 190: 147-151.
44. Stoll, B. J., N. I. Hansen, E. F. Bell, S. Shankaran, A. R. Laptook, M. C. Walsh, E. C. Hale, N. S. Newman, K. Schibler, and W. A. Carlo, et al;Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. 2010. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126: 443-456.
45. Dammann, O., E. N. Allred, A. Leviton, S. Shen-Schwarz, D. Heller, D. R. Genest, and M. H. Collins. 2004. Fetal vasculitis in preterm newborns: interrelationships, modifiers, and antecedents. Placenta 25: 788-796.
46. Ambalavanan, N., W. A. Carlo, C. T. D'Angio, S. A. McDonald, A. Das, D. Schendel, P. Thorsen, and R. D. Higgins, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. 2009. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 123: 1132-1141.
47. Yoon, B. H., R. Romero, J. K. Jun, K. H. Park, J. D. Park, F. Ghezzi, and B. I. Kim. 1997. Amniotic fluid cytokines (interleukin-6, tumor necrosis factoralpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am. J. Obstet. Gynecol. 177: 825-830.
48. Bhatia, A. M., B. J. Stoll, M. J. Cismowski, and S. E. Hamrick. 2014. Cytokine levels in the preterm infant with neonatal intestinal injury. Am. J. Perinatol. 31: 489-496.
49. Benkoe, T., S. Baumann, M. Weninger, M. Pones, C. Reck, W. Rebhandl, and R. Oehler. 2013. Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PLoS One 8: e58720.
50. Getahun, D., D. Strickland, R. S. Zeiger, M. J. Fassett, W. Chen, G. G. Rhoads, and S. J. Jacobsen. 2010. Effect of chorioamnionitis on early childhood asthma. Arch. Pediatr. Adolesc. Med. 164: 187-192.
51. Lee, S. M., J. W. Park, B. J. Kim, C. W. Park, J. S. Park, J. K. Jun, and B. H. Yoon. 2013. Acute histologic chorioamnionitis is a risk factor for adverse neonatal outcome in late preterm birth after preterm premature rupture of membranes. PLoS One 8: e79941.
52. Armstrong-Wells, J., M. Donnelly, M. D. Post, M. J. Manco-Johnson, V. D. Winn, and G. Sébire. 2015. Inflammatory predictors of neurologic disability after preterm premature rupture of membranes. Am. J. Obstet. Gynecol. 212: 212.e1-212.e9.
53. Limperopoulos, C., H. Bassan, N. R. Sullivan, J. S. Soul, R. L. Robertson, Jr., M. Moore, S. A. Ringer, J. J. Volpe, and A. J. du Plessis. 2008. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics 121: 758-765.
54. Choi, G. B., Y. S. Yim, H. Wong, S. Kim, H. Kim, S. V. Kim, C. A. Hoeffer, D. R. Littman, and J. R. Huh. 2016. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351: 933-939.
55. + cells and ileal inflammation in the ovine fetal gut. PLoS One 6: e18355.
56. Kunzmann, S., K. Glogger, J. V. Been, S. G. Kallapur, I. Nitsos, T. J. Moss, C. P. Speer, J. P. Newnham, A. H. Jobe, and B. W. Kramer. 2010. Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep. Am. J. Obstet. Gynecol. 202: 476.e1-476.e9.
57. Lee, A. J., V. A. Lambermont, J. J. Pillow, G. R. Polglase, I. Nitsos, J. P. Newnham, M. W. Beilharz, S. G. Kallapur, A. H. Jobe, and B. W. Kramer. 2011. Fetal responses to lipopolysaccharide-induced chorioamnionitis alter immune and airway responses in 7-week-old sheep. Am. J. Obstet. Gynecol. 204: 364.e17-364.e24.
58. Kuypers, E., J. J. Collins, R. K. Jellema, T. G. Wolfs, M. W. Kemp, I. Nitsos, J. J. Pillow, G. R. Polglase, J. P. Newnham, W. T. Germeraad, et al. 2012. Ovine fetal thymus response to lipopolysaccharide-induced chorioamnionitis and antenatal corticosteroids. PLoS One 7: e38257.
59. Kuypers, E., T. G. Wolfs, J. J. Collins, R. K. Jellema, J. P. Newnham, M. W. Kemp, S. G. Kallapur, A. H. Jobe, and B. W. Kramer. 2013. Intraamniotic lipopolysaccharide exposure changes cell populations and structure of the ovine fetal thymus. Reprod. Sci. 20: 946-956.
60. + Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc. Natl. Acad. Sci. USA 106: 8635-8640.
61. Ichiyama, K., H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, M. Nakaya, G. Takaesu, S. Hori, A. Yoshimura, and T. Kobayashi. 2008. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J. Biol. Chem. 283: 17003-17008.
62. Ruan, Q., V. Kameswaran, Y. Zhang, S. Zheng, J. Sun, J. Wang, J. DeVirgiliis, H. C. Liou, A. A. Beg, and Y. H. Chen. 2011. The Th17 immune response is controlled by the Rel-RORg-RORg T transcriptional axis. J. Exp. Med. 208: 2321-2333.
63. Kim, H. J., R. A. Barnitz, T. Kreslavsky, F. D. Brown, H. Moffett, M. E. Lemieux, Y. Kaygusuz, T. Meissner, T. A. Holderried, S. Chan, et al. 2015. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science 350: 334-339.
64. Black, A., S. Bhaumik, R. L. Kirkman, C. T. Weaver, and D. A. Randolph. 2012. Developmental regulation of Th17-cell capacity in human neonates. Eur. J. Immunol. 42: 311-319.
65. Yang, D., Y. Y. Sun, S. K. Bhaumik, Y. Li, J. M. Baumann, X. Lin, Y. Zhang, S. H. Lin, R. S. Dunn, C. Y. Liu, et al. 2014. Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns. J. Neurosci. 34: 16467-16481.
66. + regulatory T cells allows for their purification from expansion cultures. Blood 113: 5125-5133.
67. Bonacci, B., B. Edwards, S. Jia, C. B. Williams, M. J. Hessner, S. B. Gauld, and J. W. Verbsky. 2012. Requirements for growth and IL-10 expression of highly purified human T regulatory cells. J. Clin. Immunol. 32: 1118-1128.
68. + regulatory T cells produce CXCL8 and recruit neutrophils. Eur. J. Immunol. 41: 306-312.
69. Gibbons, D., P. Fleming, A. Virasami, M. L. Michel, N. J. Sebire, K. Costeloe, R. Carr, N. Klein, and A. Hayday. 2014. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat. Med. 20: 1206-1210.
70. + T regulatory cells. J. Immunol. 184: 3433-3441.
71. Yadav, M., S. Stephan, and J. A. Bluestone. 2013. Peripherally induced tregs-role in immune homeostasis and autoimmunity. Front. Immunol. 4: 232.
72. + regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm. Bowel Dis. 19: 2522-2534.
73. Wang, T., X. Sun, J. Zhao, J. Zhang, H. Zhu, C. Li, N. Gao, Y. Jia, D. Xu, F. P. Huang, et al. 2015. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood. Ann. Rheum. Dis. 74: 1293-1301.
74. Kryczek, I., K. Wu, E. Zhao, S. Wei, L. Vatan, W. Szeliga, E. Huang, J. Greenson, A. Chang, J. Rolinski, et al. 2011. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 186: 4388-4395.
75. Blatner, N. R., M. F. Mulcahy, K. L. Dennis, D. Scholtens, D. J. Bentrem, J. D. Phillips, S. Ham, B. P. Sandall, M. W. Khan, D. M. Mahvi, et al. 2012. Expression of RORgt marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl. Med. 4: 164ra159.
76. Hovhannisyan, Z., J. Treatman, D. R. Littman, and L. Mayer. 2011. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140: 957-965.
77. Rueda, C. M., C. B. Wells, T. Gisslen, A. H. Jobe, S. G. Kallapur, and C. A. Chougnet. 2015. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum. Immunol. 76: 65-73.
78. Dang, E. V., J. Barbi, H. Y. Yang, D. Jinasena, H. Yu, Y. Zheng, Z. Bordman, J. Fu, Y. Kim, H. R. Yen, et al. 2011. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146: 772-784.
79. Wolfs, T. G., S. G. Kallapur, C. L. Knox, G. Thuijls, I. Nitsos, G. R. Polglase, J. J. Collins, E. Kroon, J. Spierings, N. F. Shroyer, et al. 2013. Antenatal ureaplasma infection impairs development of the fetal ovine gut in an IL-1-dependent manner. Mucosal Immunol. 6: 547-556.
80. Shah, T. A., N. H. Hillman, I. Nitsos, G. R. Polglase, J. J. Pillow, J. P. Newnham, A. H. Jobe, and S. G. Kallapur. 2010. Pulmonary and systemic expression of monocyte chemotactic proteins in preterm sheep fetuses exposed to lipopolysaccharide-induced chorioamnionitis. Pediatr. Res. 68: 210-215.
81. Arenas-Hernandez, M., R. Romero, D. St Louis, S. S. Hassan, E. B. Kaye, and N. Gomez-Lopez. 2015. An imbalance between innate and adaptive immune cells at the maternal-fetal interface occurs prior to endotoxin-induced preterm birth. Cell. Mol. Immunol. DOI: 10.1038/CMI.2015.22.
82. Schober, L., D. Radnai, E. Schmitt, K. Mahnke, C. Sohn, and A. Steinborn. 2012. Term and preterm labor: decreased suppressive activity and changes in composition of the regulatory T-cell pool. Immunol. Cell Biol. 90: 935-944.
83. Nikiforou, M., J. Vanderlocht, C. A. Chougnet, R. K. Jellema, D. R. Ophelders, M. Joosten, N. Kloosterboer, B. L. Senden-Gijsbers, W. T. Germeraad, B. W. Kramer, and T. G. Wolfs. 2015. Prophylactic interleukin-2 treatment prevents fetal gut inflammation and injury in an ovine model of chorioamnionitis. Inflamm. Bowel Dis. 21: 2026-2038.